Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morrow

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
JCI Insight|May 22, 2020
Robust antibody and cellular responses induced by DNA-only vaccination for HIVStephen C De Rosa, Srilatha Edupuganti, Yunda Huang, et al.
Vaccines|December 10, 2020
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP<sup>®</sup> DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy AdultsSrilatha Edupuganti, Stephen C De Rosa, Marnie Elizaga, et al.
Mayo Clinic Proceedings|October 5, 2020
The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19Pierre Elias, Timothy J Poterucha, Sneha S Jain, et al.
JAMA Network Open|April 23, 2021
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the PandemicGeoffrey A Rubin, Amar D Desai, Zilan Chai, et al.
NPJ Vaccines|December 22, 2017
<i>In vivo</i> protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccineKaruppiah Muthumani, Bryan D Griffin, Sangya Agarwal, et al.
The Journal of Infectious Diseases|January 26, 2022
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label TrialKimberly A Kraynyak, Elliott Blackwood, Joseph Agnes, et al.
Eclinicalmedicine|January 4, 2021
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trialPablo Tebas, ShuPing Yang, Jean D Boyer, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
JCI Insight|May 22, 2020
Robust antibody and cellular responses induced by DNA-only vaccination for HIVStephen C De Rosa, Srilatha Edupuganti, Yunda Huang, et al.
Vaccines|December 10, 2020
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP<sup>®</sup> DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy AdultsSrilatha Edupuganti, Stephen C De Rosa, Marnie Elizaga, et al.
Mayo Clinic Proceedings|October 5, 2020
The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19Pierre Elias, Timothy J Poterucha, Sneha S Jain, et al.
JAMA Network Open|April 23, 2021
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the PandemicGeoffrey A Rubin, Amar D Desai, Zilan Chai, et al.
NPJ Vaccines|December 22, 2017
<i>In vivo</i> protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccineKaruppiah Muthumani, Bryan D Griffin, Sangya Agarwal, et al.
The Journal of Infectious Diseases|January 26, 2022
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label TrialKimberly A Kraynyak, Elliott Blackwood, Joseph Agnes, et al.
Eclinicalmedicine|January 4, 2021
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trialPablo Tebas, ShuPing Yang, Jean D Boyer, et al.
Pageof 24